RecruitingPhase 2Phase 3NCT05587036

Effects of Rifaximin on Gut Microbiota and Emotion

A Randomized, Triple-blind, Placebo-controlled Study on the Effect of Rifaximin on Psychobiological Functions in Healthy Men

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

60 participants

Start Date

Feb 2, 2023

Study Type

INTERVENTIONAL

Conditions

Stress Healthy Volunteers Fear

Summary

A randomized, triple-blind, placebo-controlled study on the effect of rifaximin on psychobiological functions in healthy men.

Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and a drug called Rifaximin for people with fear, healthy volunteers, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.